Blockage of Nrf2 and autophagy by L-selenocystine induces selective death in Nrf2-addicted colorectal cancer cells through p62-Keap-1-Nrf2 axis

[1]  W. Hsu,et al.  Selenocystine induces oxidative-mediated DNA damage via impairing homologous recombination repair of DNA double-strand breaks in human hepatoma cells. , 2022, Chemico-biological interactions.

[2]  N. Qinna,et al.  Nrf2/ARE axis signalling in hepatocyte cellular death , 2022, Molecular Biology Reports.

[3]  Yen-Ju Chen,et al.  The interplay of autophagy and oxidative stress in the pathogenesis and therapy of retinal degenerative diseases , 2022, Cell & Bioscience.

[4]  Dan Li,et al.  Reactive Oxygen Species as a Link between Antioxidant Pathways and Autophagy , 2021, Oxidative medicine and cellular longevity.

[5]  Yi-Ching Wang,et al.  An innovative NRF2 nano-modulator induces lung cancer ferroptosis and elicits an immunostimulatory tumor microenvironment , 2021, Theranostics.

[6]  R. Fåhraeus,et al.  Identification of a Stable, Non-Canonically Regulated Nrf2 Form in Lung Cancer Cells , 2021, Antioxidants.

[7]  L. Saso,et al.  The NRF2/KEAP1 Axis in the Regulation of Tumor Metabolism: Mechanisms and Therapeutic Perspectives , 2020, Biomolecules.

[8]  Masayuki Yamamoto,et al.  The Molecular Mechanisms Regulating the KEAP1-NRF2 Pathway , 2020, Molecular and Cellular Biology.

[9]  Chieh-Hsi Wu,et al.  NRF2 metagene signature is a novel prognostic biomarker in colorectal cancer. , 2019, Cancer genetics.

[10]  Jian-xi Wang,et al.  Nrf2 drives oxidative stress-induced autophagy in nucleus pulposus cells via a Keap1/Nrf2/p62 feedback loop to protect intervertebral disc from degeneration , 2019, Cell Death & Disease.

[11]  Yongheng Bai,et al.  Nrf2 in cancers: A double‐edged sword , 2019, Cancer medicine.

[12]  G. DeNicola,et al.  The Regulation of NRF2 by Nutrient-Responsive Signaling and Its Role in Anabolic Cancer Metabolism. , 2017, Antioxidants & redox signaling.

[13]  Xingdong Zhou,et al.  Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion , 2018, Autophagy.

[14]  M. Komatsu,et al.  Activation of p62/SQSTM1–Keap1–Nuclear Factor Erythroid 2-Related Factor 2 Pathway in Cancer , 2018, Front. Oncol..

[15]  H. Motohashi,et al.  NRF2 addiction in cancer cells , 2018, Cancer science.

[16]  J. Liu,et al.  Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor , 2017, Nature Immunology.

[17]  T. Fernández-Villa,et al.  The NRF2 transcription factor plays a dual role in colorectal cancer: A systematic review , 2017, PLoS ONE.

[18]  J. Ju,et al.  Autophagy regulated by miRNAs in colorectal cancer progression and resistance , 2017, Cancer translational medicine.

[19]  K. Tew,et al.  Chapter Ten: Selenocompounds in Cancer Therapy: An Overview , 2017, Advances in cancer research.

[20]  M. Komatsu,et al.  Regulation of the Keap1–Nrf2 pathway by p62/SQSTM1 , 2016 .

[21]  A. Thorburn,et al.  Therapeutic Targeting of Autophagy☆ , 2016, EBioMedicine.

[22]  T. Shibata,et al.  NRF2 Intensifies Host Defense Systems to Prevent Lung Carcinogenesis, but After Tumor Initiation Accelerates Malignant Cell Growth. , 2016, Cancer research.

[23]  Xiaocui Wang,et al.  NRF2 activation by antioxidant antidiabetic agents accelerates tumor metastasis , 2016, Science Translational Medicine.

[24]  M. Tsai,et al.  Se-Allylselenocysteine induces autophagy by modulating the AMPK/mTOR signaling pathway and epigenetic regulation of PCDH17 in human colorectal adenocarcinoma cells. , 2015, Molecular nutrition & food research.

[25]  C. Foyer,et al.  Glutathione--linking cell proliferation to oxidative stress. , 2015, Free radical biology & medicine.

[26]  A. Fernandes,et al.  Selenium compounds as therapeutic agents in cancer. , 2015, Biochimica et biophysica acta.

[27]  A. Daiber,et al.  Redox regulation of genome stability by effects on gene expression, epigenetic pathways and DNA damage/repair , 2015, Redox biology.

[28]  Junfei Jin,et al.  p38 mitogen-activated protein kinase/activator protein-1 involved in serum deprivation-induced human alkaline ceramidase 2 upregulation. , 2015, Biomedical reports.

[29]  G. Despouy,et al.  Interplay between ROS and autophagy in cancer cells, from tumor initiation to cancer therapy , 2014, Redox biology.

[30]  J. Hayes,et al.  The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. , 2014, Trends in biochemical sciences.

[31]  Guodong Yang,et al.  Post-transcriptional repression of FOXO1 by QKI results in low levels of FOXO1 expression in breast cancer cells. , 2014, Oncology reports.

[32]  D. Harrison,et al.  Methods for detection of mitochondrial and cellular reactive oxygen species. , 2014, Antioxidants & redox signaling.

[33]  T. Mak,et al.  Modulation of oxidative stress as an anticancer strategy , 2013, Nature Reviews Drug Discovery.

[34]  M. Marazzi,et al.  Mesenchymal Stem/Stromal Cells: A New "Cells as Drugs" Paradigm. Efficacy and Critical Aspects in Cell Therapy , 2013, Current pharmaceutical design.

[35]  C. Klaassen,et al.  Effect of Graded Nrf2 Activation on Phase-I and -II Drug Metabolizing Enzymes and Transporters in Mouse Liver , 2012, PloS one.

[36]  Scott E. Kern,et al.  Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis , 2011, Nature.

[37]  T. Mak,et al.  Regulation of cancer cell metabolism , 2011, Nature Reviews Cancer.

[38]  P. Rada,et al.  SCF/β-TrCP Promotes Glycogen Synthase Kinase 3-Dependent Degradation of the Nrf2 Transcription Factor in a Keap1-Independent Manner , 2011, Molecular and Cellular Biology.

[39]  G. Wondrak.  Redox-directed cancer therapeutics: molecular mechanisms and opportunities. , 2009, Antioxidants & redox signaling.

[40]  Tianfeng Chen,et al.  Selenocystine induces caspase-independent apoptosis in MCF-7 human breast carcinoma cells with involvement of p53 phosphorylation and reactive oxygen species generation. , 2009, The international journal of biochemistry & cell biology.

[41]  Tianfeng Chen,et al.  Selenocystine induces reactive oxygen species-mediated apoptosis in human cancer cells. , 2009, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[42]  Guido Kroemer,et al.  Autophagy in the Pathogenesis of Disease , 2008, Cell.

[43]  Wen Li,et al.  Protective role of selenium against hepatitis B virus and primary liver cancer in Qidong , 2007, Biological Trace Element Research.

[44]  J. Herman,et al.  Dysfunctional KEAP1–NRF2 Interaction in Non-Small-Cell Lung Cancer , 2006, PLoS medicine.

[45]  Masayuki Yamamoto,et al.  Nrf2-Keap1 defines a physiologically important stress response mechanism. , 2004, Trends in molecular medicine.

[46]  R. Sinha,et al.  Mechanisms of mammary cancer chemoprevention by organoselenium compounds. , 2004, Mutation research.

[47]  M. Kwak,et al.  Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[48]  I. Fridovich,et al.  Critical evaluation of the use of hydroethidine as a measure of superoxide anion radical. , 1998, Free radical biology & medicine.

[49]  L. Clark,et al.  Inhibitory effect of selenomethionine on the growth of three selected human tumor cell lines. , 1998, Cancer letters.

[50]  D. Medina,et al.  Inhibition of cdk2 kinase activity by methylselenocysteine in synchronized mouse mammary epithelial tumor cells. , 1997, Carcinogenesis.

[51]  Bruce W. Turnbull,et al.  Effects of Selenium Supplementation for Cancer Prevention in Patients With Carcinoma of the Skin: A Randomized Controlled Trial , 1996 .

[52]  B W Turnbull,et al.  Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. , 1996, JAMA.